Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

25.62
-0.1700-0.66%
Volume:226.18K
Turnover:5.93M
Market Cap:2.88B
PE:-25.40
High:26.76
Open:26.09
Low:25.56
Close:25.79
Loading ...

24H|Skyworks Solutions Sinks 22%; AMSC Soars 13%; BigBear.ai up 5% After Soaring 45% Wednesday

Tiger Newspress
·
06 Feb

Viking Therapeutics Plummeted 10% On Its Earnings Report. Here's Why.

Blockhead
·
06 Feb

Stock Track | Viking Therapeutics Plunges 10% Despite Positive Pipeline Updates on Obesity and NASH Drugs

Stock Track
·
06 Feb

Viking Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
06 Feb

Viking Therapeutics Shares Drop After Q4 EPS Miss Estimates

Benzinga
·
06 Feb

Viking Therapeutics, Inc. (VKTX): One of January’s Biggest Losers

Insider Monkey
·
06 Feb

Stock Track | Viking Therapeutics Plunges 6.75% After-Hours Despite Positive Q4 Results and Clinical Pipeline Updates

Stock Track
·
06 Feb

Viking Therapeutics reports Q4 EPS (32c), consensus (27c)

TIPRANKS
·
06 Feb

Viking Therapeutics Q4 2024 GAAP EPS $(0.32) Misses $(0.28) Estimate

Benzinga
·
06 Feb

Viking Therapeutics Q4 Income From Operations USD -46.238 Million VS. Ibes Estimate USD -38.5 Million

THOMSON REUTERS
·
06 Feb

Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update

PR Newswire
·
06 Feb

Viking Therapeutics options imply 8.9% move in share price post-earnings

TIPRANKS
·
06 Feb

Why Does Jim Cramer Prefer Eli Lilly (LLY) Over Viking Therapeutics?

Insider Monkey
·
04 Feb

Jim Cramer’s Take on Viking Therapeutics (VKTX): “Sell Viking Therapeutics and Roll it into Viking Holdings”

Insider Monkey
·
02 Feb

Jim Cramer Says ‘I Want You To Sell Viking Therapeutics, Inc. (VKTX) And Roll It Into Viking Holdings’

Insider Monkey
·
31 Jan

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know

Zacks
·
31 Jan

Viking Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?

Zacks
·
30 Jan

How to Play NVO Stock After New Drug's Success in Obesity Study

Zacks
·
29 Jan

B.Riley Financial Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)

TIPRANKS
·
28 Jan

Institutional investors control 73% of Viking Therapeutics, Inc. (NASDAQ:VKTX) and were rewarded last week after stock increased 5.7%

Simply Wall St.
·
27 Jan